WallStSmart
VYGR

Voyager Therapeutics Inc

NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY

$3.73
+2.47% today

Updated 2026-04-30

Market cap
$224.69M
P/E ratio
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
52W range
$3 – $6
Volume
0.7M

WallStSmart proprietary scores

35
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$14.89
+299.20%
12-Month target
Intrinsic (DCF)
$14.61
Margin of safety
+76.59%
0 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 144.30% QoQ
+ 76.59% below intrinsic value
Risks
- Thin margins at -296.50%
- Negative free cash flow $-30.89M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$40.91M$250.01M$80.00M$40.37M$40.37M
Net income$-46.41M$132.33M$-65.00M$-119.72M$-27.43M
EPS$-2.04
Free cash flow$-15.00M$74.66M$-18.83M$-135.06M$-30.89M
Profit margin-113.45%52.93%-81.25%-296.53%-296.50%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
VYGR$224.69M355.32.06.75.0+76.59%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Voyager Therapeutics Inc trades at $3.73. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $40.37M. with profit margins at -296.50%. Our DCF model estimates intrinsic value at $14.61.

Frequently asked questions

What is Voyager Therapeutics Inc's stock price?
Voyager Therapeutics Inc (VYGR) trades at $3.73.
Is Voyager Therapeutics Inc overvalued?
Smart Value Score 35/100 (Grade D, Sell). DCF value $14.61.
What is the price target of Voyager Therapeutics Inc (VYGR)?
The analyst target price is $14.89, representing +299.2% upside from the current price of $3.73.
What is the intrinsic value of Voyager Therapeutics Inc (VYGR)?
Based on our DCF model, intrinsic value is $14.61, a +76.6% margin of safety versus $3.73.
What is Voyager Therapeutics Inc's revenue?
TTM revenue is $40.37M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio5.57x
ROE-48.30%
Beta1.38
50D MA$3.99
200D MA$4.02
Shares out0.06B
Float0.04B
Short ratio
Avg volume0.7M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years